194 related articles for article (PubMed ID: 38931449)
21. Ubiquitin, proteasome and parkin.
Tanaka K; Suzuki T; Hattori N; Mizuno Y
Biochim Biophys Acta; 2004 Nov; 1695(1-3):235-47. PubMed ID: 15571819
[TBL] [Abstract][Full Text] [Related]
22. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
Moore DJ; Dawson VL; Dawson TM
Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
[TBL] [Abstract][Full Text] [Related]
23. [Impairment of the ubiquitin-proteasome system and neurodegeneration].
Tanaka K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Apr; 26(2):67-73. PubMed ID: 16722463
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
Lim KL
Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
[TBL] [Abstract][Full Text] [Related]
25. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
Schlossmacher MG; Shimura H
Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
[TBL] [Abstract][Full Text] [Related]
26. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin proteasome system in immune regulation and therapeutics.
Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
29. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
30. Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein.
Park SS; Do HA; Park HB; Choi HS; Baek KH
Biochem Biophys Res Commun; 2023 Feb; 645():124-131. PubMed ID: 36682332
[TBL] [Abstract][Full Text] [Related]
31. Enrichment of rare variants in E3 ubiquitin ligase genes in Early onset Parkinson's disease.
Gu X; Hou Y; Chen Y; Ou R; Cao B; Wei Q; Zhang L; Song W; Zhao B; Wu Y; Li C; Shang H
Neurobiol Aging; 2022 Jan; 109():273-278. PubMed ID: 34544586
[TBL] [Abstract][Full Text] [Related]
32. E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration.
Zeng R; Xiong Y; Lin Z; Panayi AC; Sun Y; Cao F; Liu G
Stem Cells Int; 2022; 2022():6948367. PubMed ID: 36203882
[TBL] [Abstract][Full Text] [Related]
33. Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy.
Kim SB; Hwang S; Cha JY; Lee HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474186
[TBL] [Abstract][Full Text] [Related]
34. Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease.
Al Mamun A; Uddin MS; Kabir MT; Khanum S; Sarwar MS; Mathew B; Rauf A; Ahmed M; Ashraf GM
Neurotox Res; 2020 Jun; 38(1):8-17. PubMed ID: 32157628
[TBL] [Abstract][Full Text] [Related]
35. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.
Lim KL; Dawson VL; Dawson TM
Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976
[TBL] [Abstract][Full Text] [Related]
36. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
[TBL] [Abstract][Full Text] [Related]
39. Functional roles of E3 ubiquitin ligases in prostate cancer.
Zhao Y; Li J; Chen J; Ye M; Jin X
J Mol Med (Berl); 2022 Aug; 100(8):1125-1144. PubMed ID: 35816219
[TBL] [Abstract][Full Text] [Related]
40. Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders.
Kumar P; Pradhan K; Karunya R; Ambasta RK; Querfurth HW
J Neurochem; 2012 Feb; 120(3):350-70. PubMed ID: 22098618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
